| Host&Organizing Committees | President | Young-Jin Chun (Chung-Ang University) |
|---|---|---|
| Vice-President | Kyung-Chul Choi (Chungbuk National University) | |
| Secretary General | Keon-Wook Kang (Seoul National University) | |
| Scientific Committee | Chair | Ki Taek Nam (Yonsei University) Kyung-Min Lim (Ewha Womans University) |
| General Management Committee | Chair | Donghak Kim (Konkuk University) |
| Finance Committee | Chair | Jongsun Park (Chungnam National University) |
| International Relationship Committee | Chair | Byung-Sun Choi (Chung-Ang University) |
| Educational Committee | Chair | Joo Young Lee (The Catholic University of Korea) Dal Woong Choi (Korea University) |
| Program Planning Committee | Chair | Minsoo Noh (Seoul National University) |
| Public Relations and Communication Committee | Chair | Kyoung-bok Min (Seoul National University) |
| Membership Committee | Chair | Jeong-Yun Choi (Sungkyunkwan University) |
| Fundraising Committee | Chair | Kyuhong Lee (Korea Institute of Toxicology) |
| Toxicology Database Committee | Chair | Ok-Nam Bae (Hanyang University) |
| Risk Communication Advisory Committee | Chair | Kyu-Bong Kim (Dankook University) |
| Young Scientist Committee | Chair | Bumseok Kim (Chonbuk National University) |
| May 11 (Thursday), 2023 | ||
|---|---|---|
| 12:30 |
등록 |
|
| 13:20-13:30 |
개회사 사회 : 최연식 교수 (한국폴리텍대학) |
|
| 천영진 회장 (한국독성학회) | ||
| 13:30-15:30 |
Part 1 : 감염병 치료제의 비임상평가 좌장 : 김하룡 교수 (대구가톨릭대학교) |
|
|
13:30-14:00 감염병 치료제의 효능평가 김승택 박사 (한국파스퇴르연구소) 14:00-14:30 혁신신약 개발 규제과학 고려사항 김종원 박사 (식품의약품안전처) 14:30-15:00 감염병 치료제 개발에서 약물동태 평가 이경륜 박사 (한국생명공학연구원) 15:00-15:30 감염병 치료제의 임상적 의미 이재갑 교수 (한림대 강남성심병원) |
||
| 15:30-16:00 | Break | |
| 16:00-18:00 |
Part 2 : 동물대체시험법 및 최신 독성평가 좌장 : 장민선 교수 (숙명여자대학교) |
|
|
16:00-16:30 Organoid Model을 이용한 동물대체시험법의 활용 손미영 박사 (한국생명공학연구원) 16:30-17:00 Zebrafish 이용 효능 및 독성평가 김우근 박사 (안전성평가연구소) 17:00-17:30 AI 활용 신약개발의 효능 및 독성평가 오경석 박사 (대웅제약) 17:30-18:00 3D Model(인공조직)을 이용한 대체시험법의 실제 신소라 박사 (바이오톡스텍) |
||
| 18:00-18:10 | 총평 및 폐회사 | |
| May 12 (Friday), 2023 | ||
|---|---|---|
| 08:30 | Registration | |
| 09:30-09:50 |
Welcome Remarks Dr. Young-Jin Chun (President of KSOT, Chung-Ang University) Dr. Kyung Won Seo (Director General, National Institute of Food and Drug Safety Evaluation) Dr. Eun Ju Jeong (President of Korea Institute of Toxicology)) |
|
| 09:50-10:30 |
Plenary Lecture I Chairperson: Dr. Kyung-Chul Choi (Chungbuk National University) |
|
|
AI-based Analysis of Behavior for Drug Effect and Toxicity Dr. Daesoo Kim (KAIST) |
||
| 10:30-10:40 | Break | |
| 10:40-12:10 Sponsored by KIT |
Session 1 Next Generation Risk Assessment Chairperson: Dr. Sooyeon Kim (Korea Institute of Toxicology) |
|
|
10:40-11:10 Next Generation Risk Assessment: Challenges and Opportunities in the Context of (European) Regulatory Background Dr. Annette Bitsch (Fraunhofer ITEM, Germany) 11:10-11:40 Translational Cardiotoxicity Model Systems in 2D and 3D Cultures Dr. Jan Fiedler (Fraunhofer ITEM, Germany) 11:40-12:10 Development of High-throughput Screening Assays for Hazard Identification and Characterization Dr. Michael Oelgeschlaeger (German Federal Institute of Risk Assessment, Germany) |
||
| 12:10-13:30 | Lunch / Council Meeting | |
| 13:30-14:10 |
Plenary Lecture II Chairperson: Dr. Ki Taek Nam (Yonsei University) |
|
|
New Methodology for Risk Assessment of Mixtures in the Context of Real-Life Risk Simulation Concept Dr. Anca Oana Docea (University of Medicine and Pharmacy of Craiova, Romania) |
||
| 14:10-15:40 |
Session 2 In Silico Toxicology Prediction Chairperson: Dr. Minsoo Noh (Seoul National University) |
|
|
14:10-14:40 Development of a Deep Learning Model for Predicting the Synergistic Estrogenic Effects in Binary Mixtures Dr. Myungwon Seo (Korea Research Institute of Chemical Technology) 14:40-15:10 Computational Prediction of Peptide Toxicity Using Handcrafted Features and Deep Learning Dr. Balachandran Manavalan (Sungkyunkwan University) 15:10-15:40 De Novo Drug Design with Deep Reinforcement Learning to Improve Efficacy and Safety of Drug Molecules Dr. Hyun Kil Shin (Korea Institute of Toxicology) |
||
| 15:40-16:00 | Break | |
| 16:00-17:30 Sponsored by NEXEL |
Session 3 Drug Evaluation Using Stem Cell-based Models Chairperson: Dr. Dong-Hun Woo (NEXEL Co., Ltd.) |
|
|
16:00-16:30 Modeling Heart Disease using hiPSC-derived Cardiac Organoids Dr. Myeongjin Song (NEXEL Co., Ltd.) 16:30-17:00 Human Pluripotent Stem Cell-derived Alveolar Organoid for Toxicity Assessment Dr. Se-Ran Yang (Kangwon National University) 17:00-17:30 Electrochemical Cell-based Chip for Real-time and Non-destructive Drug Screening Dr. Tae-Hyung Kim (Chung-Ang University) |
||
| 17:30–17:50 | General Assembly | |
| 17:50-18:00 | Closing Remarks | |
| 18:00 | Reception | |
Date : May. 11 (Thu) ~ 12 (Fri), 2023
Venue : Samsung Convention Center, Seoul National University, Seoul, Korea
Title : Next Generation Risk Assessment and New Approach Methods